A One Stop Shop for Everything Futures Trading
Whether you're looking to learn the basics of futures or are a seasoned vet looking to hone your trading skills, our Technical Analysis Guide has everything you need to succeed in today's futures markets!
Download your FREE Technical Analysis Trading Guide Today.

CRBP Insider Trading (Corbus Pharmaceuticals)

Insider Ownership Percentage: 8.20%
Insider Buying (Last 12 Months): $26,095.00
Insider Selling (Last 12 Months): $0.00

Corbus Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Corbus Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Corbus Pharmaceuticals Share Price & Price History

Current Price: $0.26
Price Change: Price Decrease of -0.01 (-3.75%)
As of 08/12/2022 01:00 AM ET

This chart shows the closing price history over time for CRBP up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
How Much Longer Will It Be Under $1?
The SEC and a group of high-powered lawyers have been hashing out a federally-regulated cryptocurrency.

Once ready, this crypto will become the 1st endorsed for use in the US.

I expect once the regulations are in place, this crypto's value will skyrocket.

Get into this crypto for under a dollar now.
>>>

Corbus Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/10/2022Craig Stuart MillianCOOBuy5,000$0.25$1,250.0027,000View SEC Filing Icon  
8/10/2022Sean F MoranCFOBuy20,000$0.26$5,200.00199,272View SEC Filing Icon  
8/10/2022Yuval CohenCEOBuy3,800$0.26$988.0098,230View SEC Filing Icon  
5/16/2022Sean F MoranCFOBuy12,000$0.30$3,600.00179,272View SEC Filing Icon  
5/16/2022Yuval CohenCEOBuy10,500$0.25$2,625.0094,430View SEC Filing Icon  
3/10/2022Craig Stuart MillianCOOBuy10,000$0.37$3,700.00View SEC Filing Icon  
3/10/2022Sean F MoranCFOBuy15,000$0.37$5,550.00View SEC Filing Icon  
3/9/2022Yuval CohenCEOBuy8,600$0.37$3,182.00View SEC Filing Icon  
12/21/2020Sean F MoranCFOSell87,500$1.75$153,125.00403,220View SEC Filing Icon  
12/18/2020Sean F MoranCFOSell53,610$1.40$75,054.00403,220View SEC Filing Icon  
12/16/2020Sean F MoranCFOSell36,923$1.32$48,738.36386,533View SEC Filing Icon  
11/11/2020Yuval CohenCEOBuy4,240$1.21$5,130.4075,330View SEC Filing Icon  
11/11/2020Yuval CohenCEOBuy4,240$1.21$5,130.4075,330View SEC Filing Icon  
3/17/2020Barbara WhiteInsiderBuy15,606$3.82$59,614.92
3/17/2020Robert Paul DiscordiaCOOBuy2,840$3.82$10,848.80
11/12/2019Yuval CohenCEOBuy1,430$4.26$6,091.8066,790View SEC Filing Icon  
11/11/2019Craig Stuart MillianInsiderBuy1,000$4.38$4,380.0010,000View SEC Filing Icon  
11/11/2019Robert Paul DiscordiaCOOBuy2,500$4.62$11,550.0032,650View SEC Filing Icon  
8/15/2019Craig Stuart MillianInsiderBuy1,500$5.48$8,220.009,000View SEC Filing Icon  
See Full Table
A One Stop Shop for Everything Futures Trading
Whether you're looking to learn the basics of futures or are a seasoned vet looking to hone your trading skills, our Technical Analysis Guide has everything you need to succeed in today's futures markets!
Download your FREE Technical Analysis Trading Guide Today.

SEC Filings (Institutional Ownership Changes) for Corbus Pharmaceuticals (NASDAQ:CRBP)

35.61% of Corbus Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at CRBP by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Corbus Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/13/2022Renaissance Technologies LLC1,626,860$0.41M0.0%+40.6%1.299%Search for SEC Filing on Google Icon
8/12/2022Ikarian Capital LLC862,527$0.22M0.0%-13.5%0.689%Search for SEC Filing on Google Icon
7/26/2022Mirae Asset Global Investments Co. Ltd.4,029,171$1.02M0.0%+7.3%3.217%Search for SEC Filing on Google Icon
6/2/2022Mirae Asset Global Investments Co. Ltd.3,754,954$2M0.0%-7.7%2.998%Search for SEC Filing on Google Icon
5/17/2022Jane Street Group LLC64,247$34K0.0%-41.9%0.051%Search for SEC Filing on Google Icon
5/16/2022State Street Corp395,513$0.21M0.0%+10.7%0.316%Search for SEC Filing on Google Icon
5/16/2022Vident Investment Advisory LLC255,146$0.14M0.0%+66.2%0.204%Search for SEC Filing on Google Icon
5/13/2022Renaissance Technologies LLC1,157,191$0.62M0.0%+371.0%0.924%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.4,292,163$2.28M0.0%-20.6%3.427%Search for SEC Filing on Google Icon
5/11/2022GSA Capital Partners LLP517,806$0.28M0.0%N/A0.413%Search for SEC Filing on Google Icon
5/10/2022Mirae Asset Global Investments Co. Ltd.3,754,954$2M0.0%-7.7%2.998%Search for SEC Filing on Google Icon
5/5/2022Pinnacle Associates Ltd.914,887$0.49M0.0%-3.4%0.731%Search for SEC Filing on Google Icon
4/28/2022Davy Global Fund Management Ltd435,285$0.23M0.0%+36.6%0.348%Search for SEC Filing on Google Icon
2/14/2022ETF Managers Group LLC14,138,998$8.53M0.2%+0.3%11.290%Search for SEC Filing on Google Icon
2/10/2022Acadian Asset Management LLC184,026$0.11M0.0%N/A0.147%Search for SEC Filing on Google Icon
2/8/2022Mirae Asset Global Investments Co. Ltd.4,070,006$2.51M0.0%+1.7%3.250%Search for SEC Filing on Google Icon
2/3/2022Cambridge Investment Research Advisors Inc.115,919$71K0.0%+27.5%0.093%Search for SEC Filing on Google Icon
2/2/2022Davy Global Fund Management Ltd318,668$0.20M0.0%+10.0%0.254%Search for SEC Filing on Google Icon
1/18/2022Aries Wealth Management107,800$66K0.0%+360.7%0.086%Search for SEC Filing on Google Icon
1/14/2022Spire Wealth Management45,000$28K0.0%N/A0.036%Search for SEC Filing on Google Icon
11/15/2021Penserra Capital Management LLC434,874$0.44M0.0%+19.2%0.347%Search for SEC Filing on Google Icon
11/12/2021Geode Capital Management LLC1,386,108$1.41M0.0%+2.1%1.107%Search for SEC Filing on Google Icon
11/12/2021Vident Investment Advisory LLC147,113$0.15M0.0%N/A0.117%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.2,566,443$2.62M0.0%+8.7%2.049%Search for SEC Filing on Google Icon
10/27/2021Davy Global Fund Management Ltd289,627$0.30M0.0%-90.0%0.231%Search for SEC Filing on Google Icon
10/19/2021Pinnacle Associates Ltd.966,014$0.99M0.0%-3.2%0.771%Search for SEC Filing on Google Icon
9/17/2021Virtu Financial LLC85,031$0.16M0.0%-44.3%0.068%Search for SEC Filing on Google Icon
9/3/2021Parametric Portfolio Associates LLC61,837$0.11M0.0%+126.8%0.049%Search for SEC Filing on Google Icon
8/26/2021Y Intercept Hong Kong Ltd20,467$37K0.0%N/A0.016%Search for SEC Filing on Google Icon
8/17/2021Walleye Capital LLC168,824$0.31M0.0%N/A0.135%Search for SEC Filing on Google Icon
8/17/2021Walleye Trading LLC56,659$0.10M0.0%N/A0.045%Search for SEC Filing on Google Icon
8/17/2021Millennium Management LLC1,242,977$2.28M0.0%N/A0.994%Search for SEC Filing on Google Icon
8/17/2021Price T Rowe Associates Inc. MD28,410$52K0.0%+148.3%0.023%Search for SEC Filing on Google Icon
8/17/2021Boothbay Fund Management LLC128,350$0.24M0.0%+15.7%0.103%Search for SEC Filing on Google Icon
8/16/2021LMR Partners LLP29,228$53K0.0%N/A0.023%Search for SEC Filing on Google Icon
8/16/2021Cubist Systematic Strategies LLC36,903$68K0.0%-62.9%0.030%Search for SEC Filing on Google Icon
8/16/2021Morgan Stanley2,592,114$4.74M0.0%-34.6%2.073%Search for SEC Filing on Google Icon
8/16/2021Credit Suisse AG59,269$0.11M0.0%+307.0%0.047%Search for SEC Filing on Google Icon
8/16/2021State Street Corp352,709$0.65M0.0%-77.2%0.282%Search for SEC Filing on Google Icon
8/16/2021Tibra Equities Europe Ltd145,500$0.27M0.1%N/A0.116%Search for SEC Filing on Google Icon
8/16/2021Goldman Sachs Group Inc.61,514$0.11M0.0%-71.4%0.049%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp213,327$0.39M0.0%-73.2%0.171%Search for SEC Filing on Google Icon
8/13/2021Jump Financial LLC23,466$43K0.0%N/A0.019%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC1,357,449$2.48M0.0%-15.6%1.086%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.5,462,050$10M0.0%+43.6%4.368%Search for SEC Filing on Google Icon
8/12/2021Penserra Capital Management LLC364,964$0.67M0.0%+204.2%0.292%Search for SEC Filing on Google Icon
8/12/2021Dimensional Fund Advisors LP65,794$0.12M0.0%N/A0.053%Search for SEC Filing on Google Icon
8/12/2021JPMorgan Chase & Co.187,252$0.34M0.0%-53.3%0.150%Search for SEC Filing on Google Icon
8/12/2021Bank of Montreal Can17,925$33K0.0%+763.0%0.014%Search for SEC Filing on Google Icon
8/12/2021Ergoteles LLC317,400$0.58M0.0%N/A0.254%Search for SEC Filing on Google Icon
8/11/2021Bank of New York Mellon Corp197,232$0.36M0.0%-26.2%0.158%Search for SEC Filing on Google Icon
8/11/2021BlackRock Inc.2,362,071$4.32M0.0%-58.4%1.889%Search for SEC Filing on Google Icon
8/11/2021Deutsche Bank AG54,008$98K0.0%-20.2%0.043%Search for SEC Filing on Google Icon
8/11/2021Susquehanna Fundamental Investments LLC53,033$97K0.0%-74.3%0.042%Search for SEC Filing on Google Icon
8/10/2021JTC Employer Solutions Trusteee Ltd33,185$61K0.0%N/A0.027%Search for SEC Filing on Google Icon
8/5/2021Platform Technology Partners60,000$0.11M0.0%N/A0.048%Search for SEC Filing on Google Icon
8/4/2021Graypoint LLC13,420$25K0.0%N/A0.011%Search for SEC Filing on Google Icon
8/4/2021Creative Planning238,024$0.44M0.0%-54.7%0.190%Search for SEC Filing on Google Icon
8/2/2021Pinnacle Associates Ltd.998,229$1.83M0.0%+1.5%0.798%Search for SEC Filing on Google Icon
7/31/2021Davy Global Fund Management Ltd2,884,251$5.28M0.8%+33.4%2.307%Search for SEC Filing on Google Icon
5/18/2021D. E. Shaw & Co. Inc.541,302$1.07M0.0%-73.9%0.433%Search for SEC Filing on Google Icon
5/18/2021Morgan Stanley3,961,808$7.80M0.0%+427.5%3.169%Search for SEC Filing on Google Icon
5/18/2021Cubist Systematic Strategies LLC99,565$0.20M0.0%N/A0.080%Search for SEC Filing on Google Icon
5/17/2021Royal Bank of Canada83,657$0.16M0.0%+80.2%0.067%Search for SEC Filing on Google Icon
5/17/2021HRT Financial LP118,862$0.23M0.0%-86.5%0.095%Search for SEC Filing on Google Icon
5/17/2021Nuveen Asset Management LLC253,115$2.34M0.0%+3.3%0.202%Search for SEC Filing on Google Icon
5/17/2021Ikarian Capital LLC964,100$1.90M0.1%+593.1%0.771%Search for SEC Filing on Google Icon
5/17/2021Goldman Sachs Group Inc.214,971$0.42M0.0%+253.5%0.172%Search for SEC Filing on Google Icon
5/14/2021Stifel Financial Corp12,619$25K0.0%-44.5%0.010%Search for SEC Filing on Google Icon
5/13/2021Barclays PLC64,217$0.13M0.0%N/A0.051%Search for SEC Filing on Google Icon
5/13/2021NewEdge Wealth LLC18,800$37K0.0%N/A0.015%Search for SEC Filing on Google Icon
5/13/2021Penserra Capital Management LLC119,988$0.24M0.0%+14.9%0.096%Search for SEC Filing on Google Icon
5/13/2021Bank of New York Mellon Corp267,113$0.53M0.0%+18.0%0.214%Search for SEC Filing on Google Icon
5/13/2021Citigroup Inc.16,683$33K0.0%-47.6%0.013%Search for SEC Filing on Google Icon
5/13/2021Mirae Asset Global Investments Co. Ltd.3,396,393$6.69M0.0%+65.7%2.716%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp797,449$1.57M0.0%-3.7%0.638%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC1,607,521$3.17M0.0%+14.9%1.286%Search for SEC Filing on Google Icon
5/12/2021Pinnacle Associates Ltd.983,279$1.94M0.0%+4.4%0.786%Search for SEC Filing on Google Icon
5/12/2021UBS Group AG19,668$39K0.0%+467.9%0.016%Search for SEC Filing on Google Icon
5/11/2021Davy Global Fund Management Ltd2,162,029$4.26M0.7%+3,697.6%1.729%Search for SEC Filing on Google Icon
5/11/2021AdvisorShares Investments LLC491,126$0.97M0.1%+80.6%0.393%Search for SEC Filing on Google Icon
5/10/2021Vestmark Advisory Solutions Inc.18,800$37K0.0%N/A0.015%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.5,673,664$11.18M0.0%+8.7%4.538%Search for SEC Filing on Google Icon
5/7/2021Cambridge Investment Research Advisors Inc.89,699$0.18M0.0%-9.4%0.072%Search for SEC Filing on Google Icon
5/3/2021The Manufacturers Life Insurance Company50,289$99K0.0%+30.9%0.040%Search for SEC Filing on Google Icon
4/28/2021DAVENPORT & Co LLC25,000$49K0.0%N/A0.020%Search for SEC Filing on Google Icon
4/20/2021Intersect Capital LLC14,518$29K0.0%N/A0.012%Search for SEC Filing on Google Icon
2/24/2021Virtu Financial LLC153,908$0.19M0.0%N/A0.183%Search for SEC Filing on Google Icon
2/23/2021Principal Financial Group Inc.33,163$41K0.0%+31.4%0.039%Search for SEC Filing on Google Icon
2/19/2021JPMorgan Chase & Co.259,070$0.32M0.0%+833.9%0.308%Search for SEC Filing on Google Icon
2/16/2021Squarepoint Ops LLC290,532$0.36M0.0%+314.9%0.346%Search for SEC Filing on Google Icon
2/16/2021Jefferies Group LLC20,000$25K0.0%N/A0.024%Search for SEC Filing on Google Icon
2/16/2021ETF Managers Group LLC8,103,641$10.13M0.2%+122.0%9.643%Search for SEC Filing on Google Icon
2/16/2021Charles Schwab Investment Management Inc.447,025$0.56M0.0%-7.0%0.532%Search for SEC Filing on Google Icon
2/12/2021Penserra Capital Management LLC104,408$0.13M0.0%+10.4%0.124%Search for SEC Filing on Google Icon
2/12/2021LPL Financial LLC35,825$45K0.0%+163.9%0.043%Search for SEC Filing on Google Icon
2/12/2021The Manufacturers Life Insurance Company38,411$48K0.0%+28.3%0.046%Search for SEC Filing on Google Icon
2/12/2021Ikarian Capital LLC139,100$0.17M0.0%-36.8%0.166%Search for SEC Filing on Google Icon
2/12/2021Vontobel Holding Ltd.20,539$26K0.0%N/A0.024%Search for SEC Filing on Google Icon
2/11/2021Northern Trust Corp827,845$1.04M0.0%-0.9%0.985%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Corbus Pharmaceuticals logo
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an anti-integrin monoclonal antibody (mAb) for the treatment of cancer and fibrosis that inhibits the activation of transforming growth factor ß (TGFß); and CRB-602, an anti-avß6/avß8 mAb that blocks the activation of TGFß for the treatment of fibrotic diseases. The company is also developing cannabinoid receptor type 1 inverse agonist program for the treatment of metabolic disorders, such as obesity, diabetic nephropathy, diabetic retinopathy, and nonalcoholic steatohepatitis; fibrotic diseases, including lung, cardiac, renal disease, and liver fibrosis; and other diseases comprising ascites, cognitive defects, Prader-Willi syndrome, and smoking cessation. It has a licensing agreement with Jenrin Discovery, LLC to develop and commercialize the licensed products, including the Jenrin library of approximately 600 compounds, and multiple issued and pending patent filings. The company was incorporated in 2009 and is based in Norwood, Massachusetts.
Read More on Corbus Pharmaceuticals

Today's Range

Now: $0.26
Low: $0.26
High: $0.27

50 Day Range

MA: $0.27
Low: $0.23
High: $0.30

52 Week Range

Now: $0.26
Low: $0.21
High: $1.32

Volume

2,667,527 shs

Average Volume

532,829 shs

Market Capitalization

$32.16 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.94

Who are the company insiders with the largest holdings of Corbus Pharmaceuticals?

Corbus Pharmaceuticals' top insider shareholders include:
  1. Sean F Moran (CFO)
  2. Yuval Cohen (CEO)
  3. Craig Stuart Millian (COO)
Learn More about top insider investors at Corbus Pharmaceuticals.

Who are the major institutional investors of Corbus Pharmaceuticals?

Corbus Pharmaceuticals' top institutional investors include:
  1. Mirae Asset Global Investments Co. Ltd. — 3.22%
  2. Renaissance Technologies LLC — 1.30%
  3. Ikarian Capital LLC — 0.69%
  4. Group One Trading L.P. — 0.00%
Learn More about top institutional investors of Corbus Pharmaceuticals stock.

Which major investors are selling Corbus Pharmaceuticals stock?

In the last quarter, CRBP stock was sold by these institutional investors:
  1. Ikarian Capital LLC

Which major investors are buying Corbus Pharmaceuticals stock?

In the previous quarter, CRBP stock was bought by institutional investors including:
  1. Renaissance Technologies LLC
  2. Mirae Asset Global Investments Co. Ltd.
  3. Group One Trading L.P.
Within the last year, these company insiders have bought Corbus Pharmaceuticals stock:
  1. Sean F Moran (CFO)
  2. Yuval Cohen (CEO)
  3. Craig Stuart Millian (COO)
Learn More investors buying Corbus Pharmaceuticals stock.
A One Stop Shop for Everything Futures Trading
Whether you're looking to learn the basics of futures or are a seasoned vet looking to hone your trading skills, our Technical Analysis Guide has everything you need to succeed in today's futures markets!
Download your FREE Technical Analysis Trading Guide Today.